These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24293647)

  • 21. Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery.
    Fan J; Liu Y; Kong R; Ni D; Yu Z; Lu S; Zhang J
    J Med Chem; 2021 Dec; 64(24):17728-17743. PubMed ID: 34878270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward an understanding of the sequence and structural basis of allosteric proteins.
    Li X; Chen Y; Lu S; Huang Z; Liu X; Wang Q; Shi T; Zhang J
    J Mol Graph Model; 2013 Mar; 40():30-9. PubMed ID: 23337573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation Between Allosteric and Orthosteric Sites.
    Zhang W; Xie J; Lai L
    Adv Exp Med Biol; 2019; 1163():89-105. PubMed ID: 31707701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
    Lu S; He X; Ni D; Zhang J
    J Med Chem; 2019 Jul; 62(14):6405-6421. PubMed ID: 30817889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AlloDriver: a method for the identification and analysis of cancer driver targets.
    Song K; Li Q; Gao W; Lu S; Shen Q; Liu X; Wu Y; Wang B; Lin H; Chen G; Zhang J
    Nucleic Acids Res; 2019 Jul; 47(W1):W315-W321. PubMed ID: 31069394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine learning approaches in predicting allosteric sites.
    Nerín-Fonz F; Cournia Z
    Curr Opin Struct Biol; 2024 Apr; 85():102774. PubMed ID: 38354652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FASTDock: A Pipeline for Allosteric Drug Discovery.
    Ahmed F; Brooks CL
    J Chem Inf Model; 2023 Nov; 63(22):7219-7227. PubMed ID: 37939386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncovering the Dominant Motion Modes of Allosteric Regulation Improves Allosteric Site Prediction.
    Xie J; Wang S; Xu Y; Deng M; Lai L
    J Chem Inf Model; 2022 Jan; 62(1):187-195. PubMed ID: 34964625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the Computational Identification of Allosteric Sites and Pathways in Proteins.
    Daura X
    Adv Exp Med Biol; 2019; 1163():141-169. PubMed ID: 31707703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational elucidation of allosteric communication in proteins for allosteric drug design.
    Ni D; Liu Y; Kong R; Yu Z; Lu S; Zhang J
    Drug Discov Today; 2022 Aug; 27(8):2226-2234. PubMed ID: 35314339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
    Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt.
    de Vries RMJM; Meijer FA; Doveston RG; Leijten-van de Gevel IA; Brunsveld L
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.